13G Filing: Armistice Capital and Actinium Pharmaceuticals Inc. (ATNM)

Page 10 of 10

Page 10 of 10 – SEC Filing

Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13G dated August 4, 2017 relating to the Common Stock, $0.001 par value per share, of Actinium Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
Armistice Capital, LLC
By:  /s/ Steven Boyd
Steven Boyd
Managing Member
Armistice Capital Master Fund Ltd.
By:  /s/ Steven Boyd
Steven Boyd
Director
/s/  Steven Boyd
Steven Boyd

Follow Actinium Pharmaceuticals Inc. (NYSEMKT:ATNM)

Page 10 of 10